Harnine 10 CR Tablet contains Norethisterone 10 mg, a synthetic progestogen used primarily for the management of menstrual disorders. Norethisterone exerts its pharmacological effect by mimicking the natural hormone progesterone, thereby regulating the menstrual cycle and preventing endometrial proliferation. This medication is indicated for the treatment of conditions such as secondary amenorrhea, dysfunctional uterine bleeding, and endometriosis. Additionally, it is employed to delay menstruation for short periods when clinically appropriate. Harnine 10 CR Tablet is administered orally, with dosage and duration tailored to the specific condition and patient response. The controlled-release formulation ensures a steady release of the active ingredient, promoting consistent plasma levels and improved therapeutic outcomes. Common side effects may include headache, breast tenderness, nausea, and changes in menstrual flow. Contraindications include known hypersensitivity to norethisterone or other progestogens, active thromboembolic disorders, liver dysfunction, and hormone-dependent malignancies. Caution is advised in patients with a history of cardiovascular disease or hormone-sensitive conditions. Regular monitoring and consultation with a healthcare professional are essential to optimize treatment efficacy and minimize adverse effects. Harnine 10 CR Tablet should be used under medical supervision with adherence to prescribed guidelines.